Jefferson University Hospitals

Provider Profile

Goran Rakocevic, MD

Jefferson University Physician

Academic Title: Associate Professor
Clinical Director, Jefferson Weinberg ALS Center

Neurology - Neuromuscular

Make An Appointment

Click to call 1-800-JEFF-NOW (800-533-3669) or

Office Locations

909 Walnut Street
2nd Floor, COB Bldg.
Philadelphia PA 19107
Phone: (215) 955-7952
Fax: (215) 955-9976

Medical Services

Board Certifications

  • Neurology

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital
  • Methodist Hospital Division of Thomas Jefferson University Hospital


  • University of Sarajevo, Medical School


  • Miriam Hospital
  • University of Sarajevo


  • University of Kansas Medical Center


  • National Institute of Health

Jefferson physicians accept most health insurance plans, including those listed below. However, plan acceptance may vary by practice and may be subject to change. If you have questions about whether a specific physician accepts your insurance, please contact your insurance company.

Insurances Accepted

  • Aetna
  • Aetna PA Employee Benefit Trust Fund (PEBTF)
  • AmeriHealth
  • AmeriHealth Comprehensive
  • AmeriHealth HMO
  • AmeriHealth Personal Choice
  • Blue Cross/Blue Shield
  • Cigna Healthspring
  • Cigna PPO, POS
  • Consumer Health Network PPO
  • CorVel
  • Devon
  • Employers Health Network PPO
  • Evolutions (Guardian Resources)
  • Federal BCBS
  • Geisinger Health Plan
  • Health America PPO
  • Health Management Network PPO
  • Horizon Blue Cross/Blue Shield
  • HumanaChoicePPO,Medicare,GoldPlusHMO
  • Jeff Plus
  • Keystone 65 HMO
  • Keystone First VIP Choice
  • Keystone Health Plan East
  • Medicare
  • Mercy LIFE
  • MultiPlan Inc.
  • NJ Plus
  • Personal Choice (GPPPN)
  • Personal Choice 65
  • PlanCare America
  • Preferred Care PPO
  • Premier Blue
  • Prime Health Services, Inc.
  • Qualcare
  • Tricare
  • United Healthcare
  • UPMC HMO,PPO ReadingHspEmpONLY
  • UPMC Medicare HMO
  • US Family Health Plan

Recent Publications

A double-blind, placebo-controlled study of rituximab in patients with stiff person syndrome

Single-fiber electromyography in the orbicularis oculi muscle in patients with ocular myasthenia gravis symptoms: Does abnormal jitter predict response to treatment?

Propofol as a Risk Factor for ICU-Acquired Weakness in Septic Patients with Acute Respiratory Failure

Molecular treatment effects of alemtuzumab in skeletal muscles of patients with IBM

Severe acute inflammatory demyelinating polyradiculoneuropathy with persistent weakness associated with tumor-like nerve root enlargement

Lower extremity peak force and gait kinematics in individuals with inclusion body myositis

Validity of the single limb heel raise test to predict lower extremity disablement in patients with sporadic inclusion body myositis

Thoracic Nerve, Long

Paraplegia following lumbosacral steroid epidural injections

Are repeated single-limb heel raises and manual muscle testing associated with peak plantar-flexor force in people with inclusion body myositis?

Stiff person syndrome improvement with chemotherapy in a patient with cutaneous t cell lymphoma

Pearls and oy-sters: Neurosyphilis presenting as mesial temporal encephalitis


HIV infection and antiretroviral therapy have divergent effects on mitochondria in adipose tissue

Autoimmune stiff person syndrome and related myelopathies: Understanding of electrophysiological and immunological processes

Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity

Atypical clinically diagnosed stiff-person syndrome response to dantrolene-a refractory case

Reply: Comment on alemtuzumab and inclusion body myositis

Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy

Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis